New Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting; Company to host Investor & Analyst Event on Saturday, November 11th following an oral presen

Press/Media: Press / Media

PeriodNov 7 2017

Media coverage

1

Media coverage

  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting; Company to host Investor & Analyst Event on Saturday, November 11th following an oral presen
    Media name/outletPR Newswire
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker